LF
SRPT icon

Lee Financial’s Sarepta Therapeutics SRPT Stock Holding History

Lee Financial’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15
Closed -$1.45K – 726
2023
Q4 		$1.45K Hold
15
– – ﹤0.01% 780
2023
Q3 		$1.82K Hold
15
– – ﹤0.01% 704
2023
Q2 		$1.72K Hold
15
– – ﹤0.01% 683
2023
Q1 		$2.07K Hold
15
– – ﹤0.01% 670
2022
Q4 		$1.94K Hold
15
– – ﹤0.01% 701
2022
Q3 		$2K Buy
+15
New +$1.51K ﹤0.01% 707

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Lee Financial's SRPT Position: Q1 2024 in Review

Lee Financial sold out of Sarepta Therapeutics (SRPT) in Q1 2024, closing a stake of 15 shares — an estimated $1.45K sold.

Lee Financial first reported a position in SRPT in Q3 2022 and held it in 6 quarters. The position peaked at $2.07K in Q1 2023. 414 funds tracked by Wall St. Rank hold SRPT as of Q1 2024.

  • Lee Financial reported no remaining Sarepta Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 15 Sarepta Therapeutics shares in Q1 2024, an estimated $1.45K.
  • Lee Financial first reported a position in Sarepta Therapeutics in Q3 2022 and held it in 6 quarters.
  • Lee Financial's Sarepta Therapeutics position peaked at $2.07K in Q1 2023.
  • 414 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.